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Incidental detection of pancreatic hemangioma mimicking 
a metastatic tumor of renal cell carcinoma
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Adult pancreatic hemangioma is a rare disease. We presented a case of a woman with pancreatic tail mass mimicking 
a distant metastasis from the kidney. A 68-year-old woman was found with a left kidney mass on medical checkup. 
Computed tomography scan showed a 4.3 cm-sized mass in the left kidney, suggesting renal cell carcinoma (RCC), 
and a strongly enhancing tiny nodule in the pancreatic tail. We could not rule the possibility of RCC metastasis, hence, 
surgical resection of the pancreatic mass simultaneously with radical nephrectomy for RCC was conducted. Gross 
pathologic examination revealed hemangioma. Immunohistochemistry revealed that the tumor was positive for CD34, 
CD31 and factor VIII-related antigen. There were no significant postoperative events, and the patient was discharged 
on postoperative day 7 without any complications. Treatment strategies for pancreatic hemangioma have not been 
established. To our knowledge, this was the first case report of asymptomatic pancreatic hemangioma. In previous 
literature, treatment differed on a case-by-case basis, ranging from observation to surgical resection. The most im-
portant factor in deciding whether to perform surgery is possibly risk-benefit effectiveness; however, tumor location, 
patient symptoms, and other factors are also important. (Korean J Hepatobiliary Pancreat Surg 2016;20:93-96)
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INTRODUCTION
Hemangiomas are tumors characterized by increased 
numbers of normal or abnormal vessels filled with blood. 
Occasionally, hemangiomas can occur internally, and 
nearly one-third of these internal lesions are found in the 
liver. Pancreatic hemangiomas are especially rare; pancre-
atic vascular neoplasms collectively account for only 
0.1% of all pancreatic tumors.1 These tumors are usually 
diagnosed fortuitously by laparotomies performed to diag-
nose a large, palpable abdominal mass.2-5 We presented 
a very rare case in which a woman without specific symp-
toms was found with a cavernous hemangioma in the pan-
creas tail that mimicked metastatic tumor.
CASE
A 68-year-old woman was found with a mass in her 
left kidney on medical checkup. She had no significant 
past medical history except hypertension and no symptoms 
(e.g., hematuria, abdominal pain, or abdominal discomfort). 
An axial contrast-enhanced computed tomography (CT) 
scan showed a heterogeneous solid mass in the left kidney, 
suggesting the presence of renal cell carcinoma (RCC). 
There was a strongly enhancing tiny nodule in the tail of 
the pancreas that was most likely either a neuroendocrine 
tumor or a RCC metastasis (Fig. 1A). Because she had 
no specific symptoms or abnormal laboratory findings, the 
possibility of RCC metastasizing into the pancreas could 
not be ruled out. Therefore, surgical resection, including 
left radical nephrectomy and distal pancreatectomy was 
conducted. There were no significant postoperative events, 
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Fig. 1. Imaging study and gross morphology. (A) Axial contrast-enhanced CT scan during the arterial phase shows a strongly enhancing
tiny nodule in the pancreatic tail (arrowhead); (B) Gross specimen; pancreatic hemangioma confined to the pancreas (arrow).
Fig. 2. Immunohistochemical stain shows a cavernous, ectatic endothelial neoplasm arising amid pancreatic parenchymal tissue.
(A) CD31 (100×); (B) CD34 (100×); (C) factor VIII-related antigen (100×); and (D) D2-40 (100×).
and the patient was discharged home on postoperative day 
7 without any morbidity or complications.
Gross pathologic examination revealed a 0.6×0.5 cm-sized 
hemangioma confined to the pancreas, and the tissue had 
a tumor-free margin (Fig. 1B). Immunohistochemical anal-
ysis showed that the tumor was positive for CD31, CD34, 
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and factor VIII-related antigen, and negative for D2-40, 
RCC, and CD56 (SCLC), supporting the diagnosis of he-
mangioma (Fig. 2). The left kidney mass was confirmed 
as RCC with no evidence of metastasis.
DISCUSSION
Hemangiomas rarely occur in the pancreas and often are 
not suspected clinically; only 14 patients are reported in 
the literature since 1939. Review of the previous literature 
reports on pancreatic hemangioma indicated that most he-
mangiomas occur in females (12/15 patients, including our 
patient) and are symptomatic (9/15 patients had abdominal 
pain, and one patient each had melena, thrombocytopenia, 
abdominal distension, and palpitation, suggesting bleed-
ing). Only 1 tumor was found incidentally, in 1939 upon 
autopsy.2-7
The hemangioma was found incidentally at a pre-
operative evaluation for RCC. Unlike previous studies, we 
found no symptoms suggesting pancreatic hemangioma, 
likely because it was a tiny pancreatic tail mass. Typically, 
hemangiomas are strongly contrast enhancing in the arterial 
phase of conventional contrast-enhanced CT imaging;8 
however, our case did not present these findings, likely 
because of the small lesion size. The pancreatic hemangio-
ma thus mimicked metastatic cancer originating from the 
RCC. To our knowledge, this case was the first report of 
pancreatic hemangioma without a symptomatic event, and 
the tumor is the smallest of the reported cases. After sur-
gery, the pancreatic tail tumor was pathologically con-
firmed as a hemangioma.
Microscopic findings revealed a typical feature of he-
mangioma i.e., blood-filled spaces separated by fibrous con-
nective tissue. For a definite diagnosis, immunohistochemistry 
is required to assess the presence of the factor VIII-related 
antigen, a marker for vascular endothelium that was re-
ported by Chang and colleagues.9 Subsequently, Mundinger 
and colleagues reported that neoplastic cells in hemangio-
ma also express the endothelial markers CD31 and CD34.5 
In our patient, immunohistochemical findings were positive 
for all 3 markers; whereas, D2-40, a marker for lymphatic 
endothelium, and CD56, a marker for neural cell, were 
both negative, further indicating that the tumor mass was 
a hemangioma.
Because of its rarity, there is no standard treatment for 
pancreatic hemangioma. Reviewing the previous literature 
on pancreatic hemangioma, we found that multiple differ-
ent treatments were administered, from observation to sur-
gical resection.2-7 Furthermore, the possibility of abdomi-
nal pain or hemorrhagic events is typically increased in 
patients with larger hemangioma masses. Therefore, some 
clinicians suggested that surgery is the best treatment 
option. However, other clinicians suggested that if the pa-
tient’s symptoms are minimal, observation is a possible 
treatment option, because pancreatic hemangiomas are 
benign.
The location of the pancreatic hemangioma is variable, 
and may be important for determining the best treatment 
option. Upon reviewing previous literature, we found that 
pancreatic hemangiomas were located at the head (8/15 
patients), neck (1/15 patients), or body/tail (6/15 pa-
tients).2-7 When the tumor is located at the body/tail, distal 
pancreatectomy is an option. However, if the tumor is lo-
cated at the proximal site of the pancreas, pylorus-preserv-
ing pancreaticoduodenectomy is indicated. Patients who 
underwent pylorus-preserving pancreaticoduodenectomy 
had a higher rate of morbidity than patients who under-
went distal pancreatectomy (34.7% vs. 27.8%, p＜0.05).10 
Therefore, if a patient has a pancreas head hemangioma 
with minimal symptoms that can be controlled, close ob-
servation and regular follow-up can be one of the treat-
ment options according to risk-benefit analysis. Because 
our case was confined to a tiny mass at the distal pancreas, 
and we could not rule out distant metastasis from the RCC 
tumor, we decided to perform a distal pancreatectomy.
The literature review indicated that treatment decisions 
require assessment of the severity of symptoms and loca-
tion of the tumor. When all the cases were collectively 
considered, determining the timing of surgery based on 
comparison of surgical risk-benefit analysis emerged as an 
important factor. Future reports will provide more data on 
the optimal treatment strategies for pancreatic hemangioma.
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